ADIPOQ
Adiponectin
Also known as: ACDC, ACRP30, ADIPO_HUMAN, adiponectin, apM1, GBP28
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15848
- Gene
- ADIPOQ
- Ensembl
- ENSG00000181092
- Chromosome
- 3
- Canonical length
- 244 aa
- Protein class
- Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters
- Secretome location
- Secreted to blood
- Quaternary structure
- Homomultimer
OverviewNCBI Gene
This gene is expressed in adipose tissue exclusively. It encodes a protein with similarity to collagens X and VIII and complement factor C1q. The encoded protein circulates in the plasma and is involved with metabolic and hormonal processes. Mutations in this gene are associated with adiponectin deficiency. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Apr 2010]
Canonical amino-acid sequenceUniProt
244 residues, UniProt reviewed canonical sequence.
>Q15848|ADIPOQ
1 MLLLGAVLLL LALPGHDQET TTQGPGVLLP LPKGACTGWM AGIPGHPGHN GAPGRDGRDG
61 TPGEKGEKGD PGLIGPKGDI GETGVPGAEG PRGFPGIQGR KGEPGEGAYV YRSAFSVGLE
121 TYVTIPNMPI RFTKIFYNQQ NHYDGSTGKF HCNIPGLYYF AYHITVYMKD VKVSLFKKDK
181 AMLFTYDQYQ ENNVDQASGS VLLHLEVGDQ VWLQVYGEGE RNGLYADNDN DSTFTGFLLY
241 HDTNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADIPOQ can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 843 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 843 nTPM
- breast: 253 nTPM
- blood vessel: 51 nTPM
- tongue: 19 nTPM
- salivary gland: 18 nTPM
- adrenal gland: 8.4 nTPM
Single-cell type
- adipocytes: 483 nCPM
- fibro-adipogenic progenitors: 13 nCPM
- cdc: 6.8 nCPM
- mast cells: 6.8 nCPM
- mesothelial cells: 3.3 nCPM
- pericytes: 2.4 nCPM
Immune cell
- basophil: 0.5 nTPM
- neutrophil: 0.2 nTPM
- eosinophil: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- NK-cell: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
Brain region
- white matter: 2 nTPM
- cerebellum: 1.8 nTPM
- cerebral cortex: 1.7 nTPM
- basal ganglia: 1.6 nTPM
- choroid plexus: 1.6 nTPM
- thalamus: 1.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ADIPOQ.
Disease | AllUniProt
Conditions ADIPOQ is implicated in, by any mechanism.
- Adiponectin deficiency (ADPOD) MIM:612556
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 37 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Adiponectin deficiency
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.91
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.13
- DepMap mean gene effect
- 0.17
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 1% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adiponectin-activated signaling pathway
- brown fat cell differentiation
- cellular response to cAMP
- cellular response to epinephrine stimulus
- cellular response to insulin stimulus
- cellular response to xenobiotic stimulus
- circadian rhythm
- detection of oxidative stress
- fatty acid beta-oxidation
- fatty acid oxidation
- gene expression
- generation of precursor metabolites and energy
- glucose homeostasis
- glucose metabolic process
- low-density lipoprotein particle clearance
- negative regulation of blood pressure
- negative regulation of canonical NF-kappaB signal transduction
- negative regulation of cell migration
- negative regulation of cholesterol import
- negative regulation of cold-induced thermogenesis
- negative regulation of DNA-templated transcription
- negative regulation of ERK1 and ERK2 cascade
- negative regulation of fat cell differentiation
- negative regulation of gluconeogenesis
- negative regulation of granulocyte differentiation
- negative regulation of heterotypic cell-cell adhesion
- negative regulation of hormone secretion
- negative regulation of inflammatory response
- negative regulation of macrophage derived foam cell differentiation
- negative regulation of macrophage differentiation
- negative regulation of MAP kinase activity
- negative regulation of phagocytosis
- negative regulation of platelet-derived growth factor receptor signaling pathway
- negative regulation of platelet-derived growth factor receptor-alpha signaling pathway
- negative regulation of receptor-mediated endocytosis
- negative regulation of synaptic transmission
- negative regulation of tumor necrosis factor production
- negative regulation of tumor necrosis factor-mediated signaling pathway
- negative regulation of vascular associated smooth muscle cell migration
- negative regulation of vascular associated smooth muscle cell proliferation
- positive regulation of cAMP/PKA signal transduction
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of cholesterol efflux
- positive regulation of cold-induced thermogenesis
- positive regulation of D-glucose import
- positive regulation of fatty acid metabolic process
- positive regulation of interleukin-8 production
- positive regulation of monocyte chemotactic protein-1 production
- positive regulation of signal transduction
- regulation of glucose metabolic process
- response to activity
- response to bacterium
- response to ethanol
- response to glucocorticoid
- response to glucose
- response to hypoxia
- response to linoleic acid
- response to nutrient
- response to sucrose
- response to tumor necrosis factor
- negative regulation of metanephric mesenchymal cell migration
- positive regulation of glycogen (starch) synthase activity
- positive regulation of metanephric podocyte development
- positive regulation of myeloid cell apoptotic process
- positive regulation of renal albumin absorption
Molecular functions
- cytokine activity
- hormone activity
- protein homodimerization activity
- protein serine/threonine kinase activator activity
- sialic acid binding
- signaling receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADIPOQ in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADIPOQ as an antibody target. Whether an autoantibody or antibody against ADIPOQ could matter depends on whether native ADIPOQ is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADIPOQ is annotated as secreted, so native ADIPOQ circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label ADIPOQ as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...